Schizophrenia is one of the most serious forms of psychopathology and affects one percent of people all over the globe. It is distinguished by a broad spectrum of symptoms, some of which include hallucinations, delusions, disordered thinking, and aberrant actions. a) Symptoms One may classify the symptoms of schizophrenia into two distinct groups: positive symptoms and negative symptoms. Positive symptoms include hallucinations, delusions, and disordered thinking, such as disorganized speech and mental processes. Other symptoms include paranoia and a lack of empathy. A lack of drive, emotional flatness, and trouble with social relationships are some of the negative symptoms. b) Pharmacological therapies and neurotransmitters/hormones: Antipsychotic drugs, which target certain neurotransmitters in the brain, are the primary therapy for schizophrenia. c) Psychosocial treatments: The dopamine receptor, more especially the D2 receptor, is the target of the majority of antipsychotic medications that are administered. These medications lower the activity of dopamine, which is considered to have an excessive amount of activity in those who suffer from schizophrenia. In addition to dopamine receptors, another category of antipsychotics termed atypical antipsychotics goes after serotonin receptors as its primary target. c) Heritability and genetics: Schizophrenia is known to have a significant hereditary component, with estimates placing its heritability anywhere from 70 to 80%. A number of genetic risk factors for schizophrenia have been established via research. These variables include variants in genes that are involved in dopamine and glutamate neurotransmission, as well as genes that are involved in brain development and immunological function. d) Neuroimaging and differences in the brain Researchers who used neuroimaging methods like functional magnetic resonance imaging (fMRI) discovered that people who have schizophrenia have abnormal brain activity in several regions of the brain. These regions include the prefrontal cortex, the hippocampus, and the thalamus. Studies have discovered that people who have schizophrenia have structural changes in their brains, such as less gray matter in the prefrontal cortex and the hippocampus. These structural differences may be a factor in the symptoms that are associated with the condition. Studies have discovered that patients with schizophrenia have altered dopamine function in some regions of the brain, such as the striatum and the mesolimbic system. This faulty dopamine function is believed to be a crucial mechanism that is underpinning the positive symptoms of schizophrenia. In general, schizophrenia is a complicated condition that may manifest itself in a wide variety of ways and is associated with disruptions in the function of various brain areas and neurotransmitters. Antipsychotic medicine is the primary line of defense against this condition, which also has a significant hereditary component. Research conducted using neuroimaging and other methods has shown a number of brain abnormalities and processes that may contribute to the development of the condition as well as the symptoms associated with it. 